top of page
Podcast Transcripts
Select an episode below to download a transcript.
From Access to AI – Cancer in America with Dr. Douglas Flora
Dr. Pranil Chandra and Dr. Luis Raez: Enabling Comprehensive Genomic Profiling in Lung Cancer
Dr. Debra Patt: Texas Oncology Has an “Easy Button” for Delivering Consistent Precision Oncology Care
Season 4 Episodes
Do We Have the Will to Address Inequality in Precision Medicine? A conversation with Dr. Karen Winkfield
Dr. Stephen Kingsmore on Scaling Whole Genome Sequencing for Uncovering Genetic Defects in Infants
Leading Thoracic Oncologist, Dr. Christian Rolfo, Explains How Liquid Biopsies Are Advancing Precision Medicine
LUNGevity Leaders Discuss Their Commitment to Educating Lung Cancer Patients About the Importance of Biomarker Testing
Then and Now: The Progress of Precision Medicine Diagnostics with Hannah Mamuszka and Lena Chaihorsky
Season 3
Season 3 Episodes
Author and Breast Cancer “Previvor” Ali Rogan on How Progress in Precision Medicine Empowers Patients to Make Informed Decisions
Dr. Kashyap Patel Tackles Oncology Treatment Disparities and Brings Light to the Darkest Areas of Cancer Care
Janine Morales, PhD, On Applying Precision Medicine More Strategically with Molecular Testing
Dr. Howard McLeod on Chasing the Fun and the Power of Collaboration in Precision Medicine
Bill Bonello and Clynt Taylor Examine the Future of Precision Medicine and How to Provide Better Access to More Patients
Dr. Caroline Carney and CEO Clynt Taylor Discuss Managing the Total Cost of Care in Precision Medicine
Dr. F. Anthony Greco Explains How Precision Medicine Has Led to Better Treatments for Cancers of Unknown Origins
Dr. Gabriel Bien-Willner: Helping Payers Adapt to the Paradigm Shift of Precision Medicine
AbbVie’s Christopher Boone Integrates Real-World Data with Precision Medicine for Better Patient Outcomes
Season 2
Season 2 Episodes
Precision Medicine is Coming Faster Than You Think: Rob Metcalf and Clynt Taylor
Dr. Luis Raez Discusses the Impact of Precision Medicine on Lung Cancer Treatment
Dr. Gabriel Bien-Willner: Reshaping Reimbursement Policies for Genetic and Genomic Testing
Breast Cancer Specialist Dr. Mark Moasser Discusses Overcoming Barriers to Clinical Trial Access
Lori Brisbin Explains How Trapelo Helps Keep Texas Oncology Ahead of the Precision Medicine Curve
Robin Toft on the Life Science Industry’s Talent Crisis and Why It’s Critical for CEO’s to Focus on Diversity
Dr. Roy Symthe Explains the Importance of Protein Expression in Practicing Precision Medicine
The ROS1ders: Lung Cancer Patients Turned Precision Medicine Advocates
Dr. John Quackenbush on Embracing Biological Complexity to Realize the Potential of Precision Medicine
Dr. Arturo Loaiza-Bonilla: The Impact of Precision Medicine on Gastrointestinal Disease
Precision Medicine is Here: Dr. Barbara Fortini Helps Prepare a New Generation of Scientists to Apply It
Dr. Adam Brufsky Shares Findings from the Recent San Antonio Breast Cancer Symposium and the Important Role of Precision Medicine
Dr. John Quackenbush: Using Massive Data to Approach Precision Medicine Beyond Simple Mutations
Season 1
Season 1 Episodes
Dr. Selin Kurnaz of Massive Bio Explains the Need to Operationalize Patient Support in Precision Cancer Care
Kristine Ashcraft On Advancing Precision Precision Medicine by Breaking Down Information Silos
Dr. Bruce Johnson On Expanding the Reach of Precision Medicine
Can Precision Medicine Be a Win-Win for All Stakeholders? Dr. Edward Abrahams of the PMC Believes It’s Possible
Dr. Erica Stringer-Reasor Shares Her Expertise on Precision Medicine Advancements in Breast Cancer
Nigel Russell: Creating a Community of Precision Medicine Leaders by Leveraging the Media to Drive Innovation
Dr. Jack West Part 2: Bridging the Gap Between Academic and Community Oncology for Better Precision Medicine Outcomes
Randall Broad on the Importance of Two-Way Communication Between Cancer Patients and Their Physicians
Dr. Michael Kolodziej Part Two: 3 Trends That Can Change Cancer Care Forever
Mr. Chet Burrell on how Trapelo will help payers manage the growth of precision oncology to improve care and lower costs.
Dr. Jack West of City of Hope: Why Time-Strapped Community Oncologists Aren't Applying Precision Medicine
Dr. Michael Astion and PLUGS – a Laboratory Stewardship Program to Foster Precision Medicine Best Practices
Jeanette McCarthy Returns to Discuss the Value of Pharmacogenetics in Clinical Practice
3 Trends That Can Change Cancer Care Forever: A Two-Part Podcast with Dr. Michael Kolodziej
Precision Oncology and the Science of Racial Disparities: Two Researchers Discuss the Importance of Identifying Differences | Dr. Windy Dean-Colomb and Dr. Clayton Yates
Are We There Yet? NantHealth CMO Discusses Why It’s Time for Precision Medicine in Practice
Dr. Sandeep "Bobby" Reddy, CMO NantHealth
Taking the Lead in Precision Medicine as a Surgeon
Dr. Peter Beitsch, Dallas Surgical Group + TME Breast Cancer Network
Trapelo Leaders Discuss How Collaboration Can Ease the Burdens of Prior Auth in Precision Medicine Today
Clynt Taylor, CEO, Intervention Insights
Leading the Charge: How the Personalized Medicine Coalition (PMC) Promotes Education and Advocacy
Christopher Wells, VP of Public Affairs for the Personalized Medicine Coalition
Digital Health Tools Are Disrupting Precision Medicine, and Luba Greenwood is On Board | Luba Greenwood, J.D., Strategic Business Development and Corporate Ventures at Google Life Sciences, Verily
Re-engineering Precision Medicine: a Patient Perspective on the Gap Between Innovation and Application
Brad Power, Patient Advocate and Journalist
Using Education to Overcome Barriers in Implementing Precision Medicine | Jeanette McCarthy, Precision Medicine Advisors
Are Current Genetic Testing Guidelines Outdated? A Game-Changing Study Proves the Need to Expand Breast Cancer Testing Guidelines
Dr. Peter Beitsch, Dallas Surgical Group + TME Breast Cancer Network
This is Cancer: How a Breast Cancer Diagnosis Turned Laura Holmes Haddad into an Author and Patient Advocate
Charting a Path to Prevention | Dr. Keith Stewart, Mayo Clinic
Moving Diagnostics to the Forefront of Precision Medicine
Dr. Hannah Mamuska, Alva10
Enabling Precision Oncology Using RNA-based Information and Technologies | Dr. Dave Messina, Cofactor Genomics
The Indispensable Role of Pathologists to the Future of Precision Oncology | Dr. Tony Magliocco, H. Lee Moffitt Cancer Center
bottom of page